PROVIDER PROFILE · NPI 1003958208
Milajurine LindsayP.A.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
548
Unique beneficiaries
—
Total services
712
Distinct HCPCS
7
Medicare payment
$64K
Peer benchmark
Total Medicare services vs. 32 Endocrinology providers in DC — above median (cohort median 727).
PRESCRIBING · PART D · 2024
Total Rx claims
1,218
Beneficiaries
—
Total drug cost
$749K
Distinct drugs
25
Brand share
61.8%
Top prescribed drugs
Semaglutide168 claims
Empagliflozin108 claims
Levothyroxine Sodium95 claims
Tirzepatide88 claims
Metformin Hcl81 claims
QUALITY · MIPS · 2024
Final MIPS score
81.5
Quality
67.3
Cost
72.6
Improvement activities
40.0
Promoting interop.
98.0
Payment adjustment
0.27%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$3K
Payment records
69
By payment type
Food and Beverage$3K
Top paying entities
Food and Beverage$3K
CROSS-REFERENCE